543 related articles for article (PubMed ID: 9054819)
21. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
22. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
[TBL] [Abstract][Full Text] [Related]
23. Delays in thrombolytic therapy for acute myocardial infarction: association with mode of transportation to the hospital, age, sex, and race.
Davis LL; Evans JJ; Strickland JD; Shaw LK; Wagner GS
Am J Crit Care; 2001 Jan; 10(1):35-42. PubMed ID: 11153182
[TBL] [Abstract][Full Text] [Related]
24. Fibrinolytic therapy in acute myocardial infarction: time to treatment in Canada.
Davies C; Christenson J; Campbell A; Cox JL; Huynh T; Matheson S; Daly PA; Hilbe J;
Can J Cardiol; 2004 Jun; 20(8):801-5. PubMed ID: 15229762
[TBL] [Abstract][Full Text] [Related]
25. [Acute myocardial infarction: time delay from onset of pain to hospital presentation and thrombolysis].
Ritzmann P; Frey R; Rüttimann S
Schweiz Med Wochenschr; 2000 May; 130(18):657-63. PubMed ID: 10846758
[TBL] [Abstract][Full Text] [Related]
26. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.
Hasdai D; Topol EJ; Kilaru R; Battler A; Harrington RA; Vahanian A; Ohman EM; Granger CB; Van de Werf F; Simoons ML; O'connor CM; Holmes DR
Am Heart J; 2003 Jan; 145(1):73-9. PubMed ID: 12514657
[TBL] [Abstract][Full Text] [Related]
27. Use of alteplase for myocardial infarction in two community hospitals.
Krichbaum DW; Grabavoy G; Finley RC; Hamid I
Am J Hosp Pharm; 1990 Jul; 47(7):1535-40. PubMed ID: 2114788
[TBL] [Abstract][Full Text] [Related]
28. [Indirect criteria of coronary reperfusion and permeability in patients with acute myocardial infarction who have received thrombolytic therapy].
Pereira MA; Albuquerque A; Azevedo JG; Torres S; Gomes L; Campos M; Pimenta A
Rev Port Cardiol; 1991 Mar; 10(3):229-35. PubMed ID: 1854515
[TBL] [Abstract][Full Text] [Related]
29. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
Chawla AK; Nambiar CA; Murad AA
Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
[TBL] [Abstract][Full Text] [Related]
30. Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial.
Karnash SL; Granger CB; White HD; Woodlief LH; Topol EJ; Califf RM
J Am Coll Cardiol; 1995 Dec; 26(7):1651-6. PubMed ID: 7594099
[TBL] [Abstract][Full Text] [Related]
31. Incidence of and reasons for excluding patients with acute myocardial infarction from thrombolytic therapy.
Behar S; Hod H; Barbash G; Kaplinsky E
Isr J Med Sci; 1991 Mar; 27(3):121-3. PubMed ID: 1901838
[TBL] [Abstract][Full Text] [Related]
32. Thrombolysis after acute myocardial infarction: are Canadian physicians up to the challenge?
Williams WL
CMAJ; 1997 Feb; 156(4):509-11. PubMed ID: 9054820
[TBL] [Abstract][Full Text] [Related]
33. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Pilote L; Califf RM; Sapp S; Miller DP; Mark DB; Weaver WD; Gore JM; Armstrong PW; Ohman EM; Topol EJ
N Engl J Med; 1995 Aug; 333(9):565-72. PubMed ID: 7623907
[TBL] [Abstract][Full Text] [Related]
34. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Mak KH; Moliterno DJ; Granger CB; Miller DP; White HD; Wilcox RG; Califf RM; Topol EJ
J Am Coll Cardiol; 1997 Jul; 30(1):171-9. PubMed ID: 9207639
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center.
Khalili H; Talasaz AH; Jenab Y; Salarifar M
J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):708-15. PubMed ID: 22914305
[TBL] [Abstract][Full Text] [Related]
36. [Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality].
Charbonnier B
Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):697-705. PubMed ID: 1530411
[TBL] [Abstract][Full Text] [Related]
37. Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Eur Heart J; 1995 Mar; 16(3):313-6. PubMed ID: 7789372
[TBL] [Abstract][Full Text] [Related]
38. Thrombolytic therapy in acute myocardial infarction.
Woo KS; White HD
Curr Opin Cardiol; 1994 Jul; 9(4):471-82. PubMed ID: 7919592
[TBL] [Abstract][Full Text] [Related]
39. Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience.
Gibler WB; Armstrong PW; Ohman EM; Weaver WD; Stebbins AL; Gore JM; Newby LK; Califf RM; Topol EJ;
Ann Emerg Med; 2002 Feb; 39(2):123-30. PubMed ID: 11823765
[TBL] [Abstract][Full Text] [Related]
40. [Prehospital thrombolytic therapy of acute myocardial infarct].
Tebbe U; Carlsson J
Herz; 1994 Dec; 19(6):303-13. PubMed ID: 7843687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
